252 related articles for article (PubMed ID: 23770416)
1. Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney.
Domitrović R; Cvijanović O; Pugel EP; Zagorac GB; Mahmutefendić H; Škoda M
Toxicology; 2013 Aug; 310():115-23. PubMed ID: 23770416
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
Saleh S; El-Demerdash E
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral administration of Arabic gum on cisplatin-induced nephrotoxicity in rats.
Al-Majed AA; Abd-Allah AR; Al-Rikabi AC; Al-Shabanah OA; Mostafa AM
J Biochem Mol Toxicol; 2003; 17(3):146-53. PubMed ID: 12815610
[TBL] [Abstract][Full Text] [Related]
4. Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats.
Hara M; Yoshida M; Nishijima H; Yokosuka M; Iigo M; Ohtani-Kaneko R; Shimada A; Hasegawa T; Akama Y; Hirata K
J Pineal Res; 2001 Apr; 30(3):129-38. PubMed ID: 11316323
[TBL] [Abstract][Full Text] [Related]
5. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats.
Atessahin A; Yilmaz S; Karahan I; Ceribasi AO; Karaoglu A
Toxicology; 2005 Sep; 212(2-3):116-23. PubMed ID: 15946783
[TBL] [Abstract][Full Text] [Related]
6. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of melatonin on cisplatin nephrotoxicity.
Sener G; Satiroglu H; Kabasakal L; Arbak S; Oner S; Ercan F; Keyer-Uysa M
Fundam Clin Pharmacol; 2000; 14(6):553-60. PubMed ID: 11206705
[TBL] [Abstract][Full Text] [Related]
8. Piceatannol protects against cisplatin nephrotoxicity via activation of Nrf2/HO-1 pathway and hindering NF-κB inflammatory cascade.
Wahdan SA; Azab SS; Elsherbiny DA; El-Demerdash E
Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1331-1345. PubMed ID: 31197431
[TBL] [Abstract][Full Text] [Related]
9. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
Sayed-Ahmed MM; Eissa MA; Kenawy SA; Mostafa N; Calvani M; Osman AM
Chemotherapy; 2004 Oct; 50(4):162-70. PubMed ID: 15347908
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
Atasoyu EM; Yildiz S; Bilgi O; Cermik H; Evrenkaya R; Aktas S; Gültepe M; Kandemir EG
Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats.
Dillioglugil MO; Maral Kir H; Gulkac MD; Ozon Kanli A; Ozdogan HK; Acar O; Dillioglugil O
Urol Int; 2005; 75(4):340-4. PubMed ID: 16327303
[TBL] [Abstract][Full Text] [Related]
12. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
[TBL] [Abstract][Full Text] [Related]
13. Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation.
Wu Q; Li W; Zhao J; Sun W; Yang Q; Chen C; Xia P; Zhu J; Zhou Y; Huang G; Yong C; Zheng M; Zhou E; Gao K
Biomed Pharmacother; 2021 May; 137():111308. PubMed ID: 33556877
[TBL] [Abstract][Full Text] [Related]
14. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.
Ramesh G; Reeves WB
Kidney Int; 2004 Feb; 65(2):490-9. PubMed ID: 14717919
[TBL] [Abstract][Full Text] [Related]
15. Low renal toxicity of lipoplatin compared to cisplatin in animals.
Devarajan P; Tarabishi R; Mishra J; Ma Q; Kourvetaris A; Vougiouka M; Boulikas T
Anticancer Res; 2004; 24(4):2193-200. PubMed ID: 15330160
[TBL] [Abstract][Full Text] [Related]
16. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis.
Jo SK; Cho WY; Sung SA; Kim HK; Won NH
Kidney Int; 2005 Feb; 67(2):458-66. PubMed ID: 15673293
[TBL] [Abstract][Full Text] [Related]
17. Pantoprazole abrogated cisplatin-induced nephrotoxicity in mice via suppression of inflammation, apoptosis, and oxidative stress.
Ismail RS; El-Awady MS; Hassan MH
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jul; 393(7):1161-1171. PubMed ID: 31950223
[TBL] [Abstract][Full Text] [Related]
18. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
Zhang JS; Imai T; Otagiri M
Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis.
Liu H; Baliga R
Kidney Int; 2003 May; 63(5):1687-96. PubMed ID: 12675844
[TBL] [Abstract][Full Text] [Related]
20. Ketotifen counteracts cisplatin-induced acute kidney injury in mice via targeting NF-κB/NLRP3/Caspase-1 and Bax/Bcl2/Caspase-3 signaling pathways.
Mohtadi S; Salehcheh M; Tabandeh MR; Khorsandi L; Khodayar MJ
Biomed Pharmacother; 2024 Jun; 175():116797. PubMed ID: 38776675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
